UCB
Roswell Biotechnologies Teams up With UCB on Use of Molecular Electronics Tech for Drug Development
The companies will evaluate the usefulness of Roswell's Molecular Electronics platform for drug discovery in neurological, immunological, and rare diseases.
UCB, Epilepsy Society Partner to Study Genetics of Epilepsy
The five-year deal, which is being funded by UCB, will focus in particular on epilepsy patients who do not respond to currently available treatments.
UCB Acquires Element Genomics for $30M
Element Genomics' technology will increase UCB's pipeline, focusing on target discovery and interpretation in disease relevant systems.
Startup 1Cellbio Inks Single-Cell Sequencing Collaboration With UCB
The Harvard spinout is commercializing inDrop single-cell sequencing technology developed by Allon Klein.
UCB, Harvard Collaborate on Human Microbiome Research
NEW YORK (GenomeWeb News) – UCB today announced a collaboration with researchers at Harvard to study the human microbiome in the intestine.
Mar 25, 2011
Dec 10, 2010